NLS Pharmaceutics AG (NLSP)

NASDAQ: NLSP · Real-Time Price · USD

1.50

0.03 (2.04%)

At close: Apr 29, 2025, 3:56 PM

1.54

2.67%

After-hours: Apr 29, 2025, 07:22 PM EDT

NLS Pharmaceutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-12.17M	-16.5M	-11.95M	-2.86M	-5.45M	-5.15M	-6.66M
Depreciation & Amortization	11.41K	11.41K	10.05K	72.19M	n/a	1.09M	n/a
Stock-Based Compensation	164.91K	22.73K	n/a	n/a	n/a	n/a	77.91
Other Working Capital	-8.54K	990.55K	-875.26K	580.48K	2.74M	143K	-9.79K
Other Non-Cash Items	59.53K	364.64K	166.51K	-72.12M	1.14M	1.22M	884.31K
Deferred Income Tax	n/a	613.42K	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	2.25M	1.63M	-3.17M	2.06M	4.12M	101.9K	340.29K
Operating Cash Flow	-9.68M	-13.88M	-14.94M	-729.39K	-190.01K	-2.73M	-5.43M
Capital Expenditures	-4	n/a	-39.56K	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	-3.51M	-39.56K	225.64K	-217.25K	n/a	n/a
Debt Repayment	1.63M	825.84K	-2.1M	1.19M	154.89K	n/a	3.45M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	7.35M	7.89M	-686.7K	252.59K	557.92K	3.28M
Financial Cash Flow	1.63M	17.4M	20.34M	503.52K	407.48K	557.92K	6.73M
Net Cash Flow	-8.05M	3.52M	5.34M	-126.56K	213.59K	-2.18M	1.3M
Free Cash Flow	-9.68M	-13.88M	-14.98M	-729.39K	-190.01K	-2.73M	-5.43M